Beyaz Information
What is Beyaz?
Beyaz birth control pills contain ethinyl estradiol and the new "fourth generation" progestin drospirenone (DRSP) plus 0.451 mg of levomefolate calcium, a form of folate or folic acid.
Beyaz contains the same estrogen-progestin combination as YAZ, 20 mcg ethinylestradiol (EE) / 3 mg drospirenone (DRSP). Both Beyaz and YAZ are manufactured by Bayer HealthCare Pharmaceuticals, which is the U.S.-based business arm of Bayer HealthCare LLC, a subsidiary of Bayer AG.
The only other birth control pills, or oral contraceptives, which contain ethinyl estradiol and drospirenone are:
YAZ and Yasmin from Bayer HealthCare Pharmaceuticals, Inc.;
Ocella and Gianvi from Teva Pharmaceuticals and Barr Laboratories;
Zarah from Watson Pharmaceuticals; and,
Loryna and Syeda from Sandoz, Inc.
In addition, there is
Safyral, which contains the same estrogen-progestin combination as Yasmin plus 0.451 mg of levomefolate calcium.
These birth control pills with DRSP have been associated with various adverse side effects, such as:
- Blood Clots
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Stroke
- Cerebrovascular Accidents (CVA)
- Heart Attack
- Myocardial Infarction
- Death
YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Beyaz / Safyral: Serious Side-Effects Lawsuit News And Information Hub
This is an up-to-date collection of drug injury lawyer blog posts and selected news articles regarding legal claims involving YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Beyaz / Safyral birth control pills.
Ocella, Yasmin, YAZ, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Can Cause Pulmonary Embolism, Deep Vein Thrombosis, Stroke, And Heart Attack
Some medical journal articles are linking certain birth control pills, such as Ocella, Yasmin, YAZ, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral to pulmonary embolism (PE) and deep vein thrombosis (DVT). These birth control pills each contain drospirenone (DRSP), a unique progestin which causes an increased risk of thromboembolism, or blood clot, side effects when compared to older oral contraceptives (OCs). Estrogen and DRSP create a potentially life-threatening combination due to their coagulative effects.
How And Why YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Pills Might Cause A Higher Rate Of Blood Clots In Women
All hormonal birth control options are associated with some health risks. However, the oral contraceptive pills YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral have the distinction of being associated with a possible higher rate of blood clots which can cause serious side effects – namely, stroke, heart attack, pulmonary embolism, and deep vein thrombosis. The obvious questions are “How?” and “Why?”.
Are The Current Warnings About Blood Clot Side Effects Associated With YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Sufficient?
Although the package inserts for YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral carry a bolded warning for the increased risk of hyperkalemia associated with these birth control pills, any warnings for the associated blood clot risks are found in only regular print. Now lawsuits are being filed on behalf of women who used these birth control pills alleging there has been a failure to warn about the increased risk of blood clots.
Oral Contraceptives Such As YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Found To Increase The Risk For Gallbladder Disease
Increasingly, medical studies are finding a clear and formidable link between hormonal contraceptive pills like YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral and gallbladder complications. These gallbladder injuries, such as acute cholecystitis, often end in gallbladder removal surgery, or cholecystectomy.
Pulmonary Embolism And Deep Vein Thrombosis: Symptoms, Treatment, and Recovery
For women who are using estrogen-progestin methods of birth control -- such as YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral -- here is some important information about symptoms, treatment and recovery from a blood clot, which is a serious, potentially fatal side effect of these birth control products.
YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Class Actions
We believe that people who suffered a serious injury or death due to the YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral oral contraceptive pills are better served when an individual lawsuit is filed on their behalf. A serious injury or death case should not be filed as part of any YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral class actions together with the claims of many other people who may have had different injuries caused by these birth control pills.
Legal Compensation for YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Injuries
If you experienced serious side effects from the use of YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral or a person died due to an adverse reaction while taking YAZ, Yasmin, Ocella, Gianvi, Zarah, Beyaz, or Safyral birth control pills, you may have a claim for legal compensation. Legal compensation claims involving a serious injury or death caused by the use of YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral are made by filing a lawsuit in court. All states have statutes of limitations that determine the
deadlines by which to file lawsuits involving these drospirenone (DRSP) oral contraceptives.
YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Beyaz / Safyral Information
YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral are popular birth control pills made with ethinyl estradiol (EE) and the new "fourth generation" progestin, or progesterone, drospirenone (DRSP). These four DRSP oral contraceptives have been associated with potentially fatal blood-clot side effects such as deep vein thrombosis (DVT), pulmonary embolism (PE), strokes, and heart attacks. Other associated serious side effects are gallbladder problems (cholecystitis) and gallbladder removal (cholecystectomy).
Free YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Safyral / Beyaz / Safyral Case Evaluation
The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day. Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit. We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.
Drug Injury Watch: Beyaz News And Commentary
YAZ / Yasmin Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012
Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills
Gianvi Legal Claims Against Drug Company Still Possible Despite Mensing Case Rule Against Generic Drug Injury Lawsuits
YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More)
YAZ / Yasmin: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online
Another Generic YAZ Birth Control Pill Is Approved, Just One Week Before FDA Drug Safety Meeting
Two More Medical Studies Show Increased Risk Of Blood Clots With Use Of YAZ, Yasmin, And Ocella
YAZ / Yasmin / Ocella Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Like DVT, PE, Stroke, And Heart Attack
Women Who Used YAZ / Yasmin / Ocella Are Getting Letters From Aetna Medical Insurance Company
YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary Embolism
YAZ / Yasmin / Ocella / Beyaz / Safyral: Drug Safety Regulators Focus On Blood Clot Side Effects
Yasmin / YAZ MDL: First Trial Moved From September 2011 To January 2012 Per Plaintiffs' Request
Bayer Affirms Safety Of YAZ / Yasmin And Refutes 2011 BMJ Articles About Risk Of Blood Clots
Another Rather "Odd" YAZ Label Change By Bayer: March 2011
YAZ / Yasmin / Ocella Litigation: February 2011 Update
|
